Skip to main content

#Coronavirus Disease Research #References (by AMEDEO, January 19 '25)

Image
By G.M.

 


    J Infect

  1. NURMI V, Mayne R, Knight C, Almonacid-Mendoza HL, et al
    Individual patient and donor seroprofiles in convalescent plasma treatment of COVID-19 in REMAP-CAP clinical trial.
    J Infect. 2025 Jan 9:106412. doi: 10.1016/j.jinf.2025.106412.
    PubMed         Abstract available

  2. RJOOB K, Antonelli M, Murray B, Molteni E, et al
    Symptom Evolution in Individuals with Ongoing Symptomatic COVID-19 and Post COVID-19 Syndrome After SARS-CoV-2 Vaccination Versus Influenza Vaccination.
    J Infect. 2025 Jan 10:106406. doi: 10.1016/j.jinf.2024.106406.
    PubMed         Abstract available

  3. WENDEL-GARCIA PD, Ceccato A, Motos A, Franch-Llasat D, et al
    Empirical antibiotic therapy improves outcomes in mechanically ventilated patients with COVID-19: An emulated targeted trial within a prospective, multicentre cohort study.
    J Infect. 2025 Jan 13:106411. doi: 10.1016/j.jinf.2025.106411.
    PubMed         Abstract available

  4. ROMERO-RAMIREZ A, Somasundaran A, Kontogianni K, Parkes J, et al
    Evaluation of the diagnostic accuracy of Xpert(R) Mpox and STANDARD M10 MPX/OPX for the detection of monkeypox virus.
    J Infect. 2025 Jan 15:106413. doi: 10.1016/j.jinf.2025.106413.
    PubMed         Abstract available


    J Med Virol

  5. BIRD PW, Zolana B, Oladejo S, Gurung S, et al
    Changing Patterns of Seasonal Respiratory Virus Incidence (2018-2023) Pre- and Post-COVID-19, Leicester, UK.
    J Med Virol. 2025;97:e70148.
    PubMed        

  6. HUYGHE E, Abrams S, Andre E, Anseeuw K, et al
    Systematic Molecular Influenza A/B Screening Upon Hospital Admission in Belgium, January-April 2022: Positivity Ratios and Viral Loads According to Symptomatology, Age, and Vaccination Status.
    J Med Virol. 2025;97:e70167.
    PubMed         Abstract available

  7. SANCHEZ-SIMARRO A, Cuevas-Ferrando E, Fernandez-Soto D, Grau B, et al
    Estimating SARS-CoV-2 Omicron XBB.1.5 Spike-Directed Functional Antibody Levels From an Anti-Receptor Binding Domain Wuhan-Hu-1-Based Commercial Immunoassay Results.
    J Med Virol. 2025;97:e70130.
    PubMed         Abstract available

  8. AREVALO-HERRERA M, Rincon-Orozco B, Gonzalez-Escobar JM, Herrera-Arevalo SM, et al
    Longitudinal Follow-Up of the Specific Antibody Response to SARS-CoV-2 Vaccination in Colombia.
    J Med Virol. 2025;97:e70133.
    PubMed         Abstract available

  9. CHUA HK, Singh A, Wang Y, Goh YS, et al
    Defining the Critical Requisites for Accurate Simulation of SARS-CoV-2 Viral Dynamics: Patient Characteristics and Data Collection Protocol.
    J Med Virol. 2025;97:e70174.
    PubMed         Abstract available

  10. ZHOU X, Liu H, Yang S, Dong X, et al
    Rapid Generation of Reverse Genetics Systems for Coronavirus Research and High-Throughput Antiviral Screening Using Gibson DNA Assembly.
    J Med Virol. 2025;97:e70171.
    PubMed         Abstract available

  11. ALOSAIMI B, Awadalla M, Alturaiki W, Chen Z, et al
    A 10 Year Long-Lived Cellular and Humoral MERS-CoV Immunity Cross-Recognizing the Wild-Type and Variants of SARS-CoV-2: A Potential One-Way MERS-CoV Cross-Protection Toward a Pan-Coronavirus Vaccine.
    J Med Virol. 2025;97:e70071.
    PubMed         Abstract available

  12. SILVERIO BS, Guilardi MD, Martins JO, Duro RLS, et al
    Coronavirus Cryptic Landscape and Draft Genome of a Novel CoV Clade Related to MERS From Bats Circulating in Northeastern Brazil.
    J Med Virol. 2025;97:e70173.
    PubMed         Abstract available


    J Virol

  13. NAGHIBOSADAT M, Babuadze GG, Pei Y, Hurst J, et al
    Vaccination against SARS-CoV-2 provides low-level cross-protection against common cold coronaviruses in mouse and non-human primate animal models.
    J Virol. 2025 Jan 16:e0139024. doi: 10.1128/jvi.01390.
    PubMed         Abstract available

  14. CAI C, Pham TNQ, Adam D, Brochiero E, et al
    Sensing of SARS-CoV-2-infected cells by plasmacytoid dendritic cells is modulated via an interplay between CD54/ICAM-1 and CD11a/LFA-1 alpha(L) integrin.
    J Virol. 2025 Jan 13:e0123524. doi: 10.1128/jvi.01235.
    PubMed         Abstract available


    Lancet

  15. THORNTON J
    Every Story Matters: public voices in the COVID-19 Inquiry.
    Lancet. 2025 Jan 14:S0140-6736(25)00095-9. doi: 10.1016/S0140-6736(25)00095.
    PubMed        


    Lancet Infect Dis

  16. ALVES K, Kotloff K, McClelland RS, Kouassi A, et al
    Immunogenicity and safety of a monovalent omicron XBB.1.5 SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose in US adults: interim analysis of a single-arm phase 2/3 study.
    Lancet Infect Dis. 2025 Jan 14:S1473-3099(24)00670.
    PubMed         Abstract available

  17. YADAV PD, Patil DY
    Interim analysis of SARS-CoV-2 vaccine NVX-CoV2601 as a heterologous booster dose.
    Lancet Infect Dis. 2025 Jan 14:S1473-3099(25)00005.
    PubMed        


    MMWR Morb Mortal Wkly Rep

  18. PAPA A, Barile JP, Jia H, Thompson WW, et al
    Gaps in Mental Health Care-Seeking Among Health Care Providers During the COVID-19 Pandemic - United States, September 2022-May 2023.
    MMWR Morb Mortal Wkly Rep. 2025;74:19-25.
    PubMed         Abstract available


    Science

  19. VAN KERKHOVE MD
    Don't pretend COVID-19 didn't happen.
    Science. 2025;387:229.
    PubMed         Abstract available
Labels:

Comments

Post a Comment

Popular posts from this blog

#USA, Novel #Influenza A #H5N1 Virus: One Pediatric Case in #California {FluView}

By G.M.
 {Excerpt} One confirmed human infection with influenza A(H5) virus was reported to CDC this week. To date, human-to-human transmission of influenza A(H5) virus has not been identified in the United States. This case was reported by the California Department of Public Health and occurred in a child less than 18 years old with no known contact with influenza A(H5N1) virus-infected animals or humans . The investigation into the source of infection for this case is ongoing , and no human-to-human transmission has been identified. A specimen from the individual was tested at a public health laboratory using the CDC influenza A(H5) assay before being sent to CDC for further testing. The specimen was positive for influenza A(H5) virus using diagnostic RT-PCR at CDC. Additional analysis including genetic sequencing is underway. In response to this detection, additional case investigation and contact monitoring are being conducted by public health officials in California. There have now be...
Post a Comment
Read more »

#USA, Two more #human cases of #H5N1 #birdflu reported in #California

By G.M.
Two cases of bird flu have been reported in San Joaquin County, California, local health officials said. According to a press release issued Friday and reported by the Sacramento Bee , health officials with San Joaquin County Public Health Services said both cases were farm workers who were exposed to infected animals . Both people are showing mild symptoms and are recovering, officials said, adding that there are 34 total confirmed cases across California. In a warning posted on Facebook, health officials said bird flu was “spreading in several farms such as poultry and cattle” and urged residents to take precautions to prevent the spread of the disease. Precautions include the use of protective equipment when handling poultry, dairy cattle or other animals that may be infected, and when handling raw and unpasteurized milk. (...) There are currently 60 confirmed cases of bird flu in the country . While most of the cases are in California , other states with confirmed cases include Col...
Post a Comment
Read more »

#PuertoRico - High pathogenicity avian #influenza #H5N1 viruses (#poultry) (Inf. with) - Immediate notification

By G.M.
Highly pathogenic avian influenza (HPAI) H5N1 clade 2.3.4.4b was confirmed on one poultry premises in Culebra Municipality, Puerto Rico . This is the first confirmed case of HPAI in poultry from Puerto Rico. Full genotyping confirms the virus as a reassortant of the A3 genotype with North American wild bird lineage viruses ( AM PB2, PA, NP ). Comparisons of the virus to other recent detections from wild birds and North America reports are in progress. The USDA Animal and Plant Health Inspection Service (APHIS), in conjunction with State Animal Health and Wildlife Officials, are conducting comprehensive epidemiological investigations and enhanced surveillance in response to the HPAI H5N1 related events. Source: WOAH,  https://wahis.woah.org/#/in-review/6185 _____
Post a Comment
Read more »